INCB16562, a JAK1/2 Selective Inhibitor, is Efficacious Against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support.Jun Li,Margaret Favata,Jennifer A. Kelley,Eian Caulder,Beth Thomas,Xiaoming Wen,Richard B. Sparks,Ari Arvanitis,James D. Rogers,Andrew P. Combs,Kris Vaddi,Kimberly A. Solomon,Peggy Scherle, Robert Newton,Jordan S. FridmanNeoplasia(2010)引用 87|浏览37AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要